Accredited Investors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $608K | Sell |
7,770
-1,174
| -13% | -$94.7K | 0.03% | 162 |
|
|
2026
Q1 | $775K | Sell |
8,944
-787
| -8% | -$75.4K | 0.04% | 125 |
|
|
2025
Q4 | $935K | Buy |
9,731
+83
| +0.9% | +$8.06K | 0.05% | 110 |
|
|
2025
Q3 | $919K | Sell |
9,648
-1,833
| -16% | -$169K | 0.05% | 104 |
|
|
2025
Q2 | $1M | Sell |
11,481
-482
| -4% | -$40.9K | 0.06% | 98 |
|
|
2025
Q1 | $1.08M | Buy |
11,963
+487
| +4% | +$43.6K | 0.07% | 87 |
|
|
2024
Q4 | $917K | Buy |
11,476
+42
| +0.4% | +$3.64K | 0.05% | 92 |
|
|
2024
Q3 | $1.03M | Buy |
11,434
+876
| +8% | +$73.7K | 0.06% | 92 |
|
|
2024
Q2 | $831K | Sell |
10,558
-782
| -7% | -$64.1K | 0.05% | 96 |
|
|
2024
Q1 | $988K | Sell |
11,340
-54
| -0.5% | -$4.61K | 0.06% | 92 |
|
|
2023
Q4 | $939K | Sell |
11,394
-344
| -3% | -$26.2K | 0.07% | 91 |
|
|
2023
Q3 | $920K | Buy |
11,738
+868
| +8% | +$72.7K | 0.07% | 85 |
|
|
2023
Q2 | $958K | Sell |
10,870
-883
| -8% | -$76K | 0.07% | 84 |
|
|
2023
Q1 | $948K | Sell |
11,753
-41
| -0.3% | -$3.34K | 0.07% | 78 |
|
|
2022
Q4 | $917K | Sell |
11,794
-433
| -4% | -$35.1K | 0.08% | 78 |
|
|
2022
Q3 | $987K | Sell |
12,227
-2,438
| -17% | -$219K | 0.11% | 67 |
|
|
2022
Q2 | $1.32M | Sell |
14,665
-660
| -4% | -$66.9K | 0.16% | 55 |
|
|
2022
Q1 | $1.7M | Buy |
15,325
+1,592
| +12% | +$168K | 0.15% | 50 |
|
|
2021
Q4 | $1.42M | Sell |
13,733
-2,950
| -18% | -$342K | 0.13% | 58 |
|
|
2021
Q3 | $2.09M | Sell |
16,683
-504
| -3% | -$65.2K | 0.23% | 41 |
|
|
2021
Q2 | $2.13M | Sell |
17,187
-41
| -0.2% | -$5.15K | 0.22% | 41 |
|
|
2021
Q1 | $2.04M | Buy |
17,228
+7,100
| +70% | +$832K | 0.27% | 41 |
|
|
2020
Q4 | $1.19M | Sell |
10,128
-35
| -0.3% | -$3.85K | 0.2% | 55 |
|
|
2020
Q3 | $1.06M | Buy |
10,163
+1,598
| +19% | +$160K | 0.22% | 52 |
|
|
2020
Q2 | $785K | Sell |
8,565
-49
| -0.6% | -$4.7K | 0.16% | 62 |
|
|
2020
Q1 | $777K | Buy |
8,614
+1,750
| +25% | +$186K | 0.18% | 56 |
|
|
2019
Q4 | $779K | Buy |
6,864
+736
| +12% | +$80.8K | 0.13% | 68 |
|
|
2019
Q3 | $666K | Sell |
6,128
-579
| -9% | -$60.4K | 0.13% | 67 |
|
|
2019
Q2 | $653K | Sell |
6,707
-264
| -4% | -$24.1K | 0.13% | 70 |
|
|
2019
Q1 | $635K | Buy |
6,971
+810
| +13% | +$72.5K | 0.13% | 70 |
|
|
2018
Q4 | $560K | Buy |
6,161
+11
| +0.2% | +$1.03K | 0.13% | 64 |
|
|
2018
Q3 | $605K | Sell |
6,150
-216
| -3% | -$20K | 0.15% | 58 |
|
|
2018
Q2 | $545K | Sell |
6,366
-42
| -0.7% | -$3.51K | 0.14% | 57 |
|
|
2018
Q1 | $514K | Buy |
6,408
+880
| +16% | +$72.6K | 0.14% | 62 |
|
|
2017
Q4 | $446K | Buy |
5,528
+810
| +17% | +$64.9K | 0.12% | 68 |
|
|
2017
Q3 | $367K | Buy |
4,718
+160
| +4% | +$13.3K | 0.1% | 75 |
|
|
2017
Q2 | $405K | Sell |
4,558
-2,021
| -31% | -$170K | 0.1% | 60 |
|
|
2017
Q1 | $530K | Sell |
6,579
-121
| -2% | -$9.45K | 0.13% | 55 |
|
|
2016
Q4 | $477K | Buy |
6,700
+116
| +2% | +$9.11K | 0.12% | 61 |
|
|
2016
Q3 | $569K | Sell |
6,584
-380
| -5% | -$33.1K | 0.16% | 48 |
|
|
2016
Q2 | $597K | Sell |
6,964
-663
| -9% | -$53.6K | 0.16% | 49 |
|
|
2016
Q1 | $572K | Buy |
7,627
+1,655
| +28% | +$125K | 0.15% | 47 |
|
|
2015
Q4 | $460K | Sell |
5,972
-1,477
| -20% | -$111K | 0.11% | 60 |
|
|
2015
Q3 | $499K | Buy |
7,449
+650
| +10% | +$47.9K | 0.13% | 49 |
|
|
2015
Q2 | $504K | Hold |
6,799
| – | – | 0.13% | 41 |
|
|
2015
Q1 | $531K | Sell |
6,799
-1,090
| -14% | -$82.6K | 0.14% | 41 |
|
|
2014
Q4 | $570K | Sell |
7,889
-7,072
| -47% | -$491K | 0.17% | 38 |
|
|
2014
Q3 | $927K | Sell |
14,961
-8,031
| -35% | -$511K | 0.28% | 26 |
|
|
2014
Q2 | $1.47M | Sell |
22,992
-683
| -3% | -$41.5K | 0.48% | 19 |
|
|
2014
Q1 | $1.46M | Buy |
23,675
+3,937
| +20% | +$229K | 0.49% | 19 |
|
|
2013
Q4 | $1.13M | Buy |
19,738
+116
| +0.6% | +$6.58K | 0.4% | 20 |
|
|
2013
Q3 | $1.04M | Sell |
19,622
-4,292
| -18% | -$231K | 0.39% | 21 |
|
|
2013
Q2 | $1.23M | Buy |
+23,914
| New | +$1.18M | 0.49% | 18 |
|
Other funds holding MDT
FWIA
GAM
SRIM
DC
Accredited Investors's MDT Position: Q2 2026 in Review
Accredited Investors reduced its Medtronic (MDT) stake by 13% in Q2 2026, selling an estimated $94.7K and leaving 7,770 shares worth $608K. The position accounts for 0.03% of the portfolio, ranked #162.
Accredited Investors first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.13M in Q2 2021. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Accredited Investors held 7,770 shares of Medtronic worth $608K as of Q2 2026.
- Accredited Investors sold 1,174 Medtronic shares in Q2 2026, an estimated $94.7K.
- Medtronic made up 0.03% of Accredited Investors's portfolio in Q2 2026, its #162 holding.
- Accredited Investors first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
- Accredited Investors's Medtronic position peaked at $2.13M in Q2 2021.
- 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.